Related Experiment Videos

Financial and emotional cost of bronchopulmonary dysplasia

K A McAleese1, M A Knapp, T T Rhodes

  • 1Department of Radiology, University of Arizona Medical Center, Tucson.

Clinical Pediatrics
|July 1, 1993
PubMed

Insights

Caring for infants with bronchopulmonary dysplasia (BPD) at home with oxygen therapy saves costs but increases family financial and emotional burdens. Support is crucial for successful home care.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Health Economics

Background:

  • Bronchopulmonary dysplasia (BPD) significantly prolongs infant hospitalization and medical costs.
  • Early discharge with home oxygen therapy offers cost savings but burdens families.
  • Infant respiratory disease management presents complex care challenges.

Purpose of the Study:

  • To evaluate the financial and emotional impact of home oxygen therapy for infants with BPD on families.
  • To compare the costs of home oxygen therapy with continued hospitalization.
  • To identify factors associated with successful family coping.

Main Methods:

  • Retrospective analysis of hospitalization costs for 59 infants with BPD.
  • Assessment of home oxygen therapy duration and costs.
  • Survey of family financial and emotional stress, including coping mechanisms.

Main Results:

  • Median initial hospitalization cost was $173,160 per infant.
  • Home oxygen therapy cost $5,195 for 92 days, versus projected $46,920 for hospitalization.
  • Two-thirds of families reported increased financial stress; 44% experienced emotional stress.

Conclusions:

  • Home oxygen therapy for BPD infants reduces healthcare costs but imposes significant family burdens.
  • Financial stability and adequate insurance correlate with better parental coping.
  • Comprehensive social and financial support is essential for families managing infants with BPD at home.

Related Concept Videos